A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old
Public ClinicalTrials.gov record NCT06064929. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label Phase 1b Study of Felzartamab in Lupus Nephritis
Study identification
- NCT ID
- NCT06064929
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- HI-Bio, A Biogen Company
- Industry
- Enrollment
- 14 participants
Conditions and interventions
Conditions
Interventions
- Felzartamab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2023
- Primary completion
- Jun 23, 2026
- Completion
- Jul 7, 2026
- Last update posted
- Jul 16, 2026
2023 – 2026
United States locations
- U.S. sites
- 14
- U.S. states
- 6
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, San Diego (UCSD) | La Jolla | California | 92037 | — |
| University of California, San Francisco (UCSF) | San Francisco | California | 94143 | — |
| Stanford University Medical Center | Stanford | California | 94305 | — |
| ClinCept, LLC/River City Vascular Specialists LLC | Columbus | Georgia | 31904 | — |
| Georgia Nephrology - Lawrenceville | Lawrenceville | Georgia | 30046 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Joseph S. and Diane H. Steinberg Ambulatory Care Center | Brooklyn | New York | 11201 | — |
| SUNY Downstate Medical Center | Brooklyn | New York | 11203 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| The Ohio State University (OSU) | Columbus | Ohio | 43210 | — |
| Precision Comprehensive Clinical Research Solutions - Grapevine | Grapevine | Texas | 76051 | — |
| Prolato Clinical Research Center | Houston | Texas | 77054 | — |
| Accurate Clinical Research - Katy | Katy | Texas | 77449 | — |
| R & H Clinical Research | Katy | Texas | 77450 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06064929, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 16, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06064929 live on ClinicalTrials.gov.